OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
38
Results
Show all
Save search
Copy query
Show results for
Unknown
(38)
Publication Date
Release Date
2021
(8)
2023
(7)
2022
(6)
2025
(4)
2024
(4)
2020
(4)
2019
(2)
2017
(1)
2014
(1)
2010
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
The RAPid COmmunity COGnitive screening Programme (RAPCOG): Developing the Portuguese version of the Quick Mild Cognitive Impairment (Q
mci
-P) screen as part of the EIP on AHA Twinning Scheme.
Not available
S-EPMC6581493
|
biostudies-literature
Cite
Study of the doubly charmed tetraquark [Formula: see text].
Not available
S-EPMC9203551
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594
|
biostudies-literature
Cite
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
Not available
S-EPMC8494913
|
biostudies-literature
Cite
Mammalian γ2 AMPK regulates intrinsic heart rate.
Not available
S-EPMC5668267
|
biostudies-literature
Cite
Effect of Bacille Calmette-Guerin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination.
Not available
S-EPMC11761716
|
biostudies-literature
Cite
Impacts of detritivore diversity loss on instream decomposition are greatest in the tropics.
Not available
S-EPMC8211652
|
biostudies-literature
Cite
Off-target effects of bacillus Calmette-Guerin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19.
Not available
S-EPMC9028103
|
biostudies-literature
Cite
Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.
Not available
S-EPMC10497190
|
biostudies-literature
Cite
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets